Weisblum Eric's Form 4 filing
Silo Pharma, Inc. (SILO) · filed Dec 20, 2022
- Accession no.
- 0001213900-22-081513
- Filed
- Dec 20, 2022
- Trade date
- Dec 19-20, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $889.6. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Weisblum EricCIK 0001569077 | Director, Officer (CEO and President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2022 | Common Stock | PPurchaseAcquired | +200 | $2.68 | +$536 | 154,724 | Direct | |
| Dec 20, 2022 | Common Stock | PPurchaseAcquired | +130 | $2.72 | +$353.6 | 154,854 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.